Literature DB >> 15882067

Structural characterization of the antimicrobial peptide pleurocidin from winter flounder.

Raymond T Syvitski1, Ian Burton, Neil R Mattatall, Susan E Douglas, David L Jakeman.   

Abstract

Pleurocidin is an antimicrobial peptide that was isolated from the mucus membranes of winter flounder (Pseudopleuronectes americanus) and contributes to the initial stages of defense against bacterial infection. From NMR structural studies with the uniformly (15)N-labeled peptide, a structure of pleurocidin was determined to be in a random coil conformation in aqueous solution whereas it assumes an alpha-helical structure in TFE and in dodecylphosphocholine (DPC) micelles. From (15)N relaxation studies, the helix is a rigid structure in the membrane-mimicking environment. Strong NOESY cross-peaks from the pleurocidin to the aliphatic chain on DPC confirm that pleurocidin is contained within the DPC micelle and not associated with the surface of the micelle. From diffusion studies it was determined that each micelle contains at least two pleurocidin molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882067     DOI: 10.1021/bi0504005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Structure-activity analysis of quorum-sensing signaling peptides from Streptococcus mutans.

Authors:  Raymond T Syvitski; Xiao-Lin Tian; Kamal Sampara; Alan Salman; Song F Lee; David L Jakeman; Yung-Hua Li
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

3.  Antimicrobial peptide protegrin-3 adopt an antiparallel dimer in the presence of DPC micelles: a high-resolution NMR study.

Authors:  K S Usachev; S V Efimov; O A Kolosova; E A Klochkova; A V Aganov; V V Klochkov
Journal:  J Biomol NMR       Date:  2015-03-19       Impact factor: 2.835

4.  Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor.

Authors:  P Pundir; A Catalli; C Leggiadro; S E Douglas; M Kulka
Journal:  Mucosal Immunol       Date:  2013-07-10       Impact factor: 7.313

5.  A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans.

Authors:  Junni Mai; Xiao-Lin Tian; Jeffrey W Gallant; Nadine Merkley; Zakia Biswas; Raymond Syvitski; Susan E Douglas; Junqi Ling; Yung-Hua Li
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191

6.  Cell-cell membrane fusion induced by p15 fusion-associated small transmembrane (FAST) protein requires a novel fusion peptide motif containing a myristoylated polyproline type II helix.

Authors:  Deniz Top; Jolene A Read; Sandra J Dawe; Raymond T Syvitski; Roy Duncan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

7.  Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization.

Authors:  A James Mason; Arnaud Marquette; Burkhard Bechinger
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

8.  Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L.

Authors:  Sangeetha Subramanian; Neil W Ross; Shawna L MacKinnon
Journal:  Mar Biotechnol (NY)       Date:  2009-03-31       Impact factor: 3.619

9.  Chemical shift assignment and structural plasticity of a HIV fusion peptide derivative in dodecylphosphocholine micelles.

Authors:  Charles M Gabrys; David P Weliky
Journal:  Biochim Biophys Acta       Date:  2007-08-24

10.  A method for structure-activity analysis of quorum-sensing signaling peptides from naturally transformable streptococci.

Authors:  Xiaolin Tian; Raymond T Syvitski; Tianlei Liu; Nadine Livingstone; David L Jakeman; Yung-Hua Li
Journal:  Biol Proced Online       Date:  2009-06-11       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.